Studies of the binding of small molecules to the heme in soluble type (or class) I cytochromes c have provided substantial insight into the equilibrium and kinetic properties of the heme domain, with long-standing application to understanding protein dynamics, stability, and folding (1) (2) (3) (4) (5) . In addition, exogenous ligand binding is now proving very relevant to newfound functions of cytochrome (cyt) c in apoptosis and peroxidative chemistry (reviewed in (6, 7) ).
For soluble cytochromes c and c 2 , exogenous ligands have been shown to bind to the heme with displacement of the native methionine ligand. In most cases, binding occurs preferentially to the ferric iron and causes substantial changes in the redox potential (8, 9) and spectral properties of the cytochrome (10) (11) (12) . These include cyanide, azide, fluoride, imidazole, pyridine and nitric oxide (8, 9, (13) (14) (15) . For example, binding of imidazole (Im) to oxidized mitochondrial cyt c or bacterial cyt c 2 produces a blue-shift in the Soret region, as well as changes in a number of weak absorbance bands between 450 and 600 nm (10) (11) (12) . Binding also quenches a characteristic absorption band centered at 695 nm (11, (16) (17) (18) , which is attributed to a charge transfer interaction between the oxidized heme iron (Fe 3+ ) and the sulfur of the ligating methionine residue (5, 19) . For ferrous cyt c the dissociation constant for Im is more than an order of magnitude weaker (ferrous K d ~1M, ferric K d = 30 mM (9, 10, 12, 20, 21) .
In contrast to the extensive work on cyt c and c 2 , very little is known about ligand interactions with the heme of cyt c 1 , which is a key component of the cyt bc 1 complex, a ubiquitous and ancient membrane-bound, energy transducing, electron transport protein (22, 23) . Cytochrome c 1 is an integral membrane protein with a single hydrophobic transmembrane helix and a globular heme-binding domain with a typical c-type heme covalently attached to the protein by thioether linkages to two cysteine residues. A histidine and a methionine provide the fifth and sixth heme iron ligands, respectively. Although the globular domain shares many of the properties and folds of type I cytochromes c, the sequence has little homology with that of cyt c or c 2 (22, 24, 25) and cyt c 1 is assigned to a separate class. The unusual structural features of cytochrome c 1 have been most convincingly accounted for by Baymann et al. (24) . By comparing sequences of cyt c 1 from different species, they suggested that the expanded regions of cyt c 1 arose by evolution from a di-heme cytochrome c 4 that lost the second heme. This hypothesis nicely explains why the globular heme-binding domain of cytochromes c 1 is up to two times larger than cyt c, with the major expansion in the C-terminal (or distal) half of the protein.
Mutational studies on cyt c 1 have shown that changing the endogenous methionine ligand significantly modifies the midpoint potential of cyt c 1 (26) (27) (28) (29) . However, very little has been reported for exogenous ligand interactions with the c 1 heme. Schejter and Berke (30) found cyanide to bind to isolated bovine cyt c 1 , with K d ≈ 4 mM, but Potter (31) found no effect of 10 mM cyanide on mitochondrial cyt bc 1 , in situ. Osyzcka et al. (32) reported that cyanide binds tightly to ferric cyt c 1 from Rba. capsulatus, with K d ≈ 25 µM, but only partially inhibits cyt bc 1 . GuergovaKuras et al. (33) found that His-tagged bc 1 complex from Rba. sphaeroides was inhibited when isolated with imidazole. This was attributed to lowering of E m7 of cyt c 1 induced by imidazole binding on the basis of its known interaction with cyt c.
In this work we describe and characterize the reversible binding of imidazole (Im) to cyt c 1 in isolated cyt bc 1 complex from Rba. sphaeroides, causing a large drop in midpoint potential and full inhibition of cyt bc 1 activity. We discuss the implications of the thermodynamics of Im binding in terms of the dynamics of the heme domain and the peptide sequence that contains the 6 th axial ligand of the c 1 heme iron, and use molecular dynamics to illustrate the probable mode of interaction of Im in the heme pocket. The kinetics of Im binding are described in (Kokhan et al., accompanying article), and reveal novel, transient interactions of the ligand with the protein, leading to facilitated entry into the heme pocket.
EXPERIMENTAL PROCEDURES
The strain of Rba. sphaeroides with a hexahistidine tag attached to the C-terminus of cyt b was generously provided by Dr. A. R. Crofts (strain BC17 carrying the pGB11BH6 plasmid (33) ). Cells were grown photosynthetically at 30°C on Sistrom's medium with 2 µg/ml of tetracycline and 10 µg/ml of kanamycin. Rba. sphaeroides cells were collected by 10 min centrifugation at 8,000 g and resuspended with 50 mM MOPS, pH 7.0, 100 mM KCl (buffer B). DNase I was added to a concentration of 10 µg/ml. The cells were disrupted with a French press at 17,000 psi and debris was removed by 20-min centrifugation at 48,000 g. The supernatant was centrifuged for 90 min at 140,000 g and the pellet was resuspended in buffer B.
Cytochrome bc 1 complex was isolated from Rba. sphaeroides chromatophores and purified in a single step by following the protocol described by Guergova-Kuras et al. (33) with modifications. Unless otherwise specified, bc 1 complex was isolated as follows: 10 ml of chromatophores A 375 = 50 OD were mixed with 10 ml of Ni-NTA resin equilibrated in buffer B (1:2 v/v). DM was added to a final concentration of 1% (w/v) and stirred at 4°C for 40 min. The mixture was transferred to a column and the resin was packed while eluting. The column (packed volume ≈3 ml) was washed with buffer B plus 20 mM cholate, 1 mM ascorbate at 1 ml/min for 90-120 min. bc 1 complex was eluted with buffer B plus 20 mM cholate, 1 mM ascorbate, 10 mM EDTA). The bc 1 complex was washed by repeated dilution with buffer B plus 20 mM cholate and concentration using Centriplus (Amicon Inc, Beverley, MA) concentrators with 10 kDa cutoff, and finally concentrated to ~50 µM, mixed with glycerol (to 20% v/v), and stored at -80°C.
Ni-NTA resin was obtained from Qiagen (Hilden, Germany). Decyl-ubiquinone was either from BioMol (Plymouth Meeting, PA) or from Sigma (St. Louis, MO). Horse heart cytochrome c (C2506) and all other chemicals were purchased from Sigma. Dodecyl maltoside (DM) was purchased from Anatrace (Maumee, OH). Decylubiquinol (DQH 2 ) was prepared from decyl ubiquinone as described by Trumpower and Edwards (34) .
The rate of electron transfer from decylubiquinol to cyt c catalyzed by bc 1 was measured from the rate of reduction of cyt c using the extinction coefficient Δε 551-540 = 18.5 mM -1 cm -1 (35) , in a buffer containing 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 25 µM cyt c, 20 µM DQH 2 , 0.01% DM and 10-20 nM of bc 1 complex, at room temperature, using an Agilent 8453 spectrophotometer, unless otherwise stated. Nonenzymatic electron transport was measured in the same buffer in the absence of the enzyme and the rate was subtracted from the enzymatic one.
Imidazole binding was monitored either by following spectral changes at ∆A 416-400 or by adding ascorbate and diaminodurene (DAD, 2,3,5,6-tetramethyl-p-phenylenediamine) to final concentrations of 1 mM and 10 µM, respectively, at various times after incubation with imidazole and measuring the fraction of cyt c 1 reduced rapidly (t 1/2 < 1 s). Since the cyt c 1 -imidazole complex has a much lower midpoint potential than free cyt c 1 , only the latter is promptly reduced after mixing with ascorbate/DAD. Ferricyanide-oxidized bc 1 complex (100 µM ferricyanide and bc 1 complex, containing 0.5-2 µM of cyt c 1 (Δε 552-541 = 20 mM -1 cm -1 , (36)) in 50 mM Tris, pH 8.0, 100 mM NaCl, 20 mM cholate) was incubated with various amounts of imidazole at room temperature or on ice.
Imidazole binding to heme (free or in protein) is well established to occur through the deprotonated nitrogen (11, 37) . Literature values for the pK a of both imidazole and Nmethylimidazole are 6.95-7.05 and they are generally considered the same (38, 39) . At pH 8, used here, both are 90% deprotonated, and concentrations and concentration dependent parameters, e.g., K d , are given in terms of total concentration of Im or MeIm, without correction.
Kinetic measurements of reactions with rate constants slower than 0.5 s -1 were typically performed on a diode-array Agilent 8453 spectrophotometer (integration time 100 ms) equipped with a UV blocking filter (Corning CS 0-52, cutoff wavelength 320 nm) to prevent a light-induced reduction of cyt c 1 . All reactions faster than 1 s -1 were studied using an Applied Photophysics SX-17MV stopped-flow spectrophotometer, with mixing time less than 2 ms and integration time 2.5 ms. Reactions with rate constants in 0.5-1 s -1 range were typically studied using both instruments to provide overlap of the measurement ranges.
Molecular dynamics simulations of imidazole bound to cyts c, c 2 and c 1 were done on the Turing cluster operated by the Computational Science and Enginering program at the University of Illinois, using the NAMD molecular dynamics program (40) . All simulations were performed at constant particle number, pressure (1 atm) and temperature (300K) following the procedure of Autenrieth et al. (41) , with the CHARMM 27 force field (42, 43) and standard NAMD parameters.
Atom coordinates for simulation of horse heart cyt c with Im were taken from the 1FI7.pdb NMR structure (14) . For cyt c 2 the coordinates were from the 1CXA.pdb X-ray structure (13) . All simulations on ligand interaction with cyt c 1 of Rba. sphaeroides were performed on the globular domain from 2FYN.pdb (44) . All crystallographic water molecules were removed and each protein was placed in a water-filled box (see supplemental information). Preparation of the imidazole-bound state of cyt c 1 was initiated by "opening" the heme cleft by pulling on the methionine sulfur atom in a short (1-2 ns) simulation, until the force dropped due to reorientation of the Met-185 sidechain (at about 600 pN).
Four simulations (10-25 ns) were performed for each protein: one with the imidazole ring oriented at 0° (for cyts c and c 2 this corresponds to the known structures) and three simulations where the imidazole plane was rotated 90, 180 and 270° around the axis perpendicular to the heme plane. For cyt c 1 , the 0° position was based on the 1CXA structure for cyt c 2 , by aligning the hemes.
RESULTS

Spectral properties of the imidazole-cyt c 1 complex
Incubation of fully oxidized Rba. sphaeroides bc 1 complex with Im resulted in significant spectral changes, similar to those reported for cytochromes c and c 2 (11, 12, 45) . The most prominent features of the difference spectrum were a peak at 400 nm and trough at 416 nm, with an isosbestic point at 406 nm ( Fig. 1) , indicating that Im interacts directly with cyt c 1 causing a blue shift in the Soret peak at ≈ 414 nm. There was also a decrease in absorption around 700 nm (Fig. 1, inset) . The wavelength and approximate extinction coefficient (0.2-0.5 mM -1 cm -1 ) of this feature are consistent with a characteristic absorbance attributed to the methionine S-heme Fe 3+ bond, suggesting that Im displaces the methionine ligand from the heme of cyt c 1 , as previously observed for ferricytochrome c (11, 18) and c 2 (10, 45, 46) . No imidazole-induced spectral changes were seen for the ascorbatereduced bc 1 complex (cyt c 1 and iron-sulfur center reduced, both b-hemes oxidized), indicating sole involvement of ferric cytochrome c 1 in the absorbance changes under oxidizing conditions ( Fig. 1, dotted line) .
Redox behavior of the cytochrome c 1 -Im complex In the presence of imidazole, the cyt c 1 heme becomes non-reducible by ascorbate/DAD (Fig. 2) , except on a time scale of several minutes, which we ascribe to reduction after the release of Im. The midpoint potential of ascorbate is not very well defined, due to irreversibility (47), but Elberry et al. (48) found that isolated bc 1 complexes with mutant cyt c 1 with E m ≈ +50 mV were 25-40% reducible by ascorbate. Thus, the midpoint potential of the c 1 -Im complex is significantly less than +50 mV. However, it is very rapidly (<1s) reduced by sodium dithionite (E h ≤ -300 mV), indicating that at sufficiently low potential the c 1 -Im complex can be reduced directly rather than after release of Im. This is confirmed by the more distinct peak at 550 nm ( Fig. 2B , black). This feature decayed slowly to the native spectrum with a lifetime of about 90s, reflecting the slow unbinding of Im from the ferrous heme.
The implied large drop in midpoint potential of cyt c 1 with bound Im provides a convenient assay of the fraction of cyt c 1 with bound ligandonly uncomplexed cyt c 1 (E m7 ≈ 260 mV, (49)) can be quickly reduced by ascorbate/DAD. A similar assay was used by Osyzcka et al. (32) to monitor binding of cyanide to cyt bc 1 .
Binding of imidazole to cytochrome c 1 Binding of imidazole by cyt c 1 is quite tight but slow. At 25 °C, Im binding to cyt c 1 was sufficiently fast that the kinetics and end-point values could be readily monitored by the spectral changes in the Soret band at 416-400 nm. Figure  3A shows kinetic traces obtained at 25 °C with Im concentrations ranging from 0.1 to 5 mM. From the amplitudes of the final absorbance change we estimated K d = 0.33 ± 0.07 mM (Fig. 3B) .
At lower temperatures, the rate of binding decreased dramatically. At 15 °C, binding could still be assayed by the spectral change in the Soret band, and gave K d = 0.12±0.015 mM. At 0 °C, however, binding was extremely slow, especially at the lowest Im concentrations, and was followed over a period of 10 days (Fig. 4B) . The extent of binding at each time point was measured by the reducibility of cyt c 1 by ascorbate/DAD (Fig. 4A ). This yielded a dissociation constant, K d = 40±7 µM (Fig. 4C) 1 Binding of N-methylimidazole induced an identical spectral change to that of imidazole in the Soret region (not shown), and was assayed using the same wavelength pair 400-minus-416 nm. However, MeIm binding was much faster than Im (Fig. 5) 21) ), the inhibition of activity was measured only for bc 1 complex preincubated with Im and then diluted into the assay medium. The initial turnover of the bc 1 complex saturated with 10 mM imidazole was fully inhibited (Fig. 6 ), which was confirmed by measurements with 10-fold higher concentration of bc 1 complex. However, after a short delay of a few seconds, cyt bc 1 complex inhibited by Im showed recovery of the turnover rate during the time course, concomitant with the slow release of Im from cyt c 1 (see Fig. 4A ).
DISCUSSION
Ligand binding to c-type hemes
The binding of small molecules to c-type hemes has been widely studied in type I cytochromes c, where displacement of the native methionine ligand is accompanied by conformational changes in the heme binding domain (13, 14, 45) . The mechanism of binding is still under debate, but the equilibrium properties are well established for many small molecules and depend on the nature of the exogenous ligand and the environment provided by the heme pocket.
The 
X-ray structures of Rba. sphaeroides cyt c 2 (13) and solution NMR structures of oxidized horse heart cyt c (14) have revealed the nature of the binding interactions of Im within the heme pocket of these small, soluble cytochromes. In both cases, the imidazole binds to the heme iron through the N ε atom, displacing the native methionine ligand and necessitating significant rearrangement of the backbone and side chains located near the Met residue. In addition, in cyt c 2 , a hydrogen bond is formed between the imidazole N δ H and an internal water molecule that is bound to the carbonyls of Phe102 and Val80 (13) . Hydrogen bonding is not seen in the cyt c-Im adduct (14) , and it is considered to be the primary origin of the greater affinity of cyt c 2 for Im (10). Thus, our results comparing Im and MeIm binding to cyt c 1 suggest that Im may be able to form a hydrogen bond to the protein (either directly or through a shared water molecule, as in cyt c 2 ), which is not possible for MeIm.
In cytochromes c and c 2 , the methionine ligand of the heme is located in the middle of a 12-18 residue linker connecting two α-helices of the conserved cytochrome c fold (Fig. 7, left) . NMR and x-ray crystallography studies of cyts c and c 2 with exogenous ligands bound show that part of the linker sequence (termed the "hinge" by Dumortier et al. (45) ) is rotated to relocate the methionine sidechain; this is accompanied by a slight opening or loosening of the heme binding cavity (13) (14) (15) . The initial and final states are generally referred to as closed and open.
The crystal structure of the cyt bc 1 complex from Rba. sphaeroides shows that the 6 th ligand to the heme iron of cyt c 1 is also methionine (Met185), but the surrounding organization is very different from that of cyts c and c 2 . In particular, Met185 is located in a much longer sequence (68 amino acids -residues 137-205) between the two conserved α-helices (Fig. 7,  right) . This long "hinge" sequence is mostly an extended and random coil structure that is stabilized by a short antiparallel β-strand and, uniquely in Rhodobacter, a disulfide bond between Cys145 and Cys169. Despite the larger size of cyt c 1 , especially in the heme domain, the c 1 heme is remarkably more exposed than is typical of type I cytochromes c. Apart from the solvent exposure, the immediate protein environment of the heme distal pocket is less polar in cyt c 1 than in cyt c 2 . Nevertheless, structural components are present in cyt c 1 that offer opportunities for Im to hydrogen bond, as seen in cyt c 2 . We tested this with molecular dynamics simulations on potential cyt c 1 hemeimidazole adducts.
Molecular dynamics simulations of the cyt c 1 -Im complex
Simulations of in silico-generated cyt c 1 -Im complexes were compared with simulations of the known structures of Im adducts of cyts c and c 2 (imidazole orientations denoted "0°") and with starting structures where the Im was placed in three other orientations, rotated 90°, 180° and 270° about the Fe-N axis. In 10-20 ns trajectories, the rotation of the imidazole plane and water contact with the imidazole N δ were followed. (See supplemental information.)
As a control, the "0°" (crystallographic) orientation in cyt c 2 maintained a stable position about +17° from the starting position, with r.m.s fluctuations of ±12°. The "270°" simulation also quickly found the same stable orientation. In contrast, the "90°" and "180°" orientations in cyt c 2 both rotated to about 200°, i.e., approx. 180° from the orientation adopted by the "0°" starting structure, with similar r.m.s fluctuations. This presumably reflects some barriers to rotation that are not readily surmounted in short trajectories.
For cytochrome c 1 , the "90°", "180°" and "270°" imidazole positions all reoriented quickly (<50 ps) to about 110°, with r.m.s fluctuations of ±15°, while the "0°" orientation rotated to about 20° but was less stable. Cyt c exhibited significantly larger fluctuations, especially for the "180°" and"270°" starting positions. The "0°" and "90°" orientations settled into apparently stable positions between 115 and 135°. In all cases, major fluctuations were between orientations related by approximately 90° or 180° flips.
Water contact with the imidazole N δ was categorized according to number of waters, distance, and stability (see supplemental information). Cyt c was by far the "wettest" with up to 7 water molecules within 4Å of N δ , but with rapid exchange between many different water molecule identities for all starting Im positions. The "0°" (NMR structure) orientation exhibited the most stable water associations, but showed exchange of dozens of water molecules. For cyt c 2 , N δ was contacted by 0-2 water molecules (very rarely 3). For the "0°" (crystallographic orientation) and "270°" starting orientations, only 1 or 2 waters were present at all times, and the same water molecule maintained the closest contact for more than 98% of the time, consistent with its function as a hydrogen bonding bridge between the imidazole and the peptide backbone.
In the case of cyt c 1 , 1-3 water molecules were generally present (within 4Å of N δ ), and very rarely as many as 4. In three orientations, all waters entered and left the cavity quite rapidly. However, in the "180°" starting orientation of the Im, one particular molecule was closest to the imidazole N δ more than 93% of the time, reflecting the simultaneous formation of three stable hydrogen bonds with N δ of imidazole and the carbonyl oxygens of Met185 and Pro186 (Fig.  8) .
Two other MD simulations of cyt c 1 ("90°" and "270°") converged to the same +110° angle, but without a stably bound water molecule. In both these simulations, waters in the heme binding cavity were exchanged much more quickly than seen for the "0°" trajectory. Instead, direct hydrogen bonds were formed between the N δ atom of imidazole and the carbonyl oxygens of either Ala184 or Met185, respectively, in the "90°" and "270°" simulations (see supplemental information). Thus, a role for hydrogen bonding of imidazole in the cyt c 1 heme is strongly implicated by the MD simulations, although the precise configuration is uncertain.
Thermodynamics of ligand binding
The equilibrium binding of Im to cyt c 1 is driven by a large enthalpy change (∆H° = -56 kJ mol -1 ) and the reaction exhibits a significant decrease in entropy (∆S° = -121 J mol -1 K -1 ). These values for cyt c 1 are similar to those found for Im binding to cyt c 2 : ∆H° = -49 kJ mol -1 and ∆S° = -104 J mol -1 K -1 (10) . 1 The thermodynamic parameters for cyts c 1 and c 2 are consistent with a significant conformational change and bond re-arrangement accompanying the enthalpically favorable insertion of Im. (See Table 1 (11), but all reports on the binding of Im by cyt c and by metmyoglobin and methemoglobin are qualitatively similar in showing binding to be entropically driven (11, 52, 53) .
The quantitative differences between the enthalpic and entropic contributions to Im and MeIm binding to cyt c 1 are extreme but are well supported by the activation energies for binding and release rates of the two ligands (see Kokhan et al., accompanying article). Furthermore, the qualitative differences reflect the chemical attributes of the two ligands. The magnitudes of the thermodynamic contributions for both ligands strongly implicate the protein and significant solvation responses, and the qualititative differences between Im and MeIm reveal the strongly correlated nature of the enthalpy and entropy changes, associated with hydrogen bond formation (54, 55) .
The enthalpic drive of Im binding is consistent with its ability to form one or more hydrogen bonds through N δ H, either directly to the protein (Fig. S3) or through a sequestered water molecule (Fig. 8) . The smaller size of Im compared to MeIm may also allow a somewhat 1 Dumortier et al. (10) appear to misstate their own findings for the temperature dependence of their equilibrium and kinetic data, both by a factor of 2. 6 . The values we quote were obtained by plotting the data in their Table III. by guest on September 16, 2017 http://www.jbc.org/ Downloaded from stronger Fe-N bond, providing additional enthalpic drive. However, the favorable enthalpy is substantially countered by strong negative entropy contributions. These will include degrees of freedom that are lost upon sequestration of the ligand, which should be similar for both Im and MeIm, and additional entropy losses for any bound water(s) that are likely to be unique to Im. Entropic contributions may also arise from structural reorganization of the protein, and the ability of Im to engage in hydrogen bonds within the reconfigured heme cleft will limit the flexibility of the protein and contribute a further loss of entropy.
In the case of MeIm, binding is enthalpically unfavorable but is driven by a large positive entropy. The inability to form a hydrogen bond in the final heme-ligated state and steric clashes between the methyl group and the heme and protein contribute to the positive enthalpy. Steric conflicts may also weaken the Fe-N bond. The lack of a hydrogen bond within the heme cleft will also contribute to the substantial entropy increase by allowing greater conformational mobility of the protein. An additional entropy increase is expected for transfer of the hydrophobic methyl group from the aqueous phase to the heme cleft.
Electrochemical properties of the cyt c 1 -Im complex Binding of Im to horse heart cyt c results in a ~400 mV potential drop, to -135 mV (8, 9) , consistent with replacement of the native methionine ligand, yielding an imidazole-histidine ligated heme with properties similar to those of a typical bis-his heme. In both Rba. capsulatus and sphaeroides cyt c 1 , substitution of histidine for methionine as the 6 th ligand led to photosynthetic incompetence, which was attributed to the lower redox potential of the mutant cyt c 1 (26, 29, 56) . However, redox titrations of the Met-›His mutation in Rba. capsulatus cyt c 1 showed a major titration component with E m7 = -140 mV (26, 28, 56) , while the same mutation in cyt c 1 from Rba. sphaeroides yielded a significantly higher E m7 = +74 mV (29) . The unreliability of the growth criterion is evident in comparing the functionality of Rba. sphaeroides mutant bc 1 complexes with the Met-›His substitution and those with the structurally stabilizing disulfide link (Cyt145-Cys169) removed, which have E m7 = 48-64 mV depending on the specific mutation (57) .
The latter are able to grow photosynthetically in spite of the lower midpoint potential. Guergova-Kuras et al. (33) reported that the Rba. sphaeroides His-tagged bc 1 complex isolated with imidazole in the elution buffer was less than 5% active and had two fractions of cyt c 1 : 70% showed a midpoint potential of +146 mV, a decrease of only ~120 mV, while the remaining fraction had the native high potential of +270 mV. However, we found that the cyt c 1 -Im complex was not reducible by ascorbate and concluded that the c 1 -Im midpoint potential is significantly lower than +50 mV, which would be more consistent with the established response of soluble cyt c to Im binding. It seems very likely that the previous redox titration of cyt c 1 does not represent a true equilibrium condition, which would require maintaining a very high concentration of imidazole, sufficient to saturate the low affinity of the reduced heme. For titration of cyt c, Liu et al. (9) used concentrations of 4-6 M imidazole and derivatives. At non-saturating levels, the release of Im upon heme reduction and the slow kinetics of the binding equilibrium can be expected to lead to non-equilibrium titration that would overestimate the midpoint potential and give rise to heterogeneous behavior. Furthermore, in our hands, oxidized cyt c 1 in isolated bc 1 complex is extremely susceptible to inactivation when dilute, and this has so far precluded us performing any redox titrations that are reversible in terms of enzyme activity.
Imidazole inhibition of bc 1 complex activity We found that activity assays of the imidazoleinhibited bc 1 complex from Rba. sphaeroides display two distinct phases. During the initial phase, the catalytic turnover rate was indistinguishable from the non-catalytic rate of reduction of cyt c by DQH 2 , and certainly no more than 1% of control values. However, after a clear lag (≈5 s), the bc 1 complex-catalyzed rate of cyt c reduction began to accelerate (Fig. 7A) . This behavior was qualitatively consistent and to be expected from unbinding of the ligand upon dilution. However, it was quantitatively very variable with the time and extent of recovery dependent on detergent, lipid and bc 1 preparation, and is currently under further investigation.
In normal turnover of the bc 1 complex, or ubiquinol:cytochrome c oxidoreductase, quinol is oxidized in a bifurcated process that directs the two electrons along separate pathways, in a process known as the Q-cycle. One electron passes through a sequence of high potential components, via the 2Fe2S cluster of the ironsulfur protein (ISP) followed by cytochrome c 1 and then to a soluble c-type cytochrome, while the other electron goes through a low potential sequence, via two b-type hemes to a quinone (reviewed in (58-61) ).
In its position between ISP and cyt c, cyt c 1 participates in two electron transfer reactions, and lowering of the E m of cyt c 1 by Im is a plausible mechanism of inhibition of bc 1 activity. However, it is unlikely to be a direct effect on the rate of electron transfer, as Marcus theory does not give good account of the absolute values of the electron transfer rates between ISP, c 1`a nd c or c 2 . Nevertheless, it is instructive in estimating the possible response to changes in driving force (∆E m at pH 8, where ∆G° ≈ 0 mV (62) , and between cyt c 1 and bound cyt c in yeast bc 1 complex is about 10 4 s -1 , also with ∆G° ≈ 0 mV (63) . For a reorganization energy of 1 eV, Marcus theory predicts that a 300 mV decrease in the midpoint potential of cyt c 1 would make the ISP-›c 1 rate 3 orders of magnitude slower, i.e., ≈10 2 s -1 . At the same time, the rate of electron transfer from c 1 to c should be increased by about 100-fold, i.e., ≈10 6 s -1 . Thus, ISP-›c 1 electron transfer would become rate limiting in this segment of the high potential chain. However, this is much faster than the observed rate and would not limit turnover. A 400 mV decrease in E m , as seen for soluble cyt c, would cause roughly 10-fold larger changes, but would not substantially alter this conclusion even if Marcus theory were applicable. In fact, neither of these individual electron transfer rates is very dependent on driving force (62) (63) (64) . Instead, we note that if the E m of cyt c 1 is lowered by 300 mV, the population of reduced c 1 formed in the ISP-›c 1 step will be decreased by a factor of 10 -5 (a 400 mV decrease in E m would lower the population by almost 10 -7 fold). This would have a dramatic effect on the overall rate of electron transfer from ISP to cyt c, especially if the intrinsic electron transfer rate from c 1 to c is not substantially accelerated by the increased potential drop. Thus, the large decrease in equilibrium population of reduced c 1 will be the major inhibitory influence on the turnover time of cyt c reduction.
Ligand binding and function. The affinities of imidazole and N-methylimidazole binding to cyt c 1 differ by a factor 30 and exhibit very different temperature dependences. Comparison with the binding of imidazole to cyts c and c 2 suggests that imidazole may form a hydrogen bond within the heme pocket of cyt c 1 , and molecular dynamics simulations gave strong support to this. The binding of Im to cyt c 1 was found to be enthalpically driven while MeIm was entropically driven. This marked qualitative difference was accounted for in terms of their hydrogen bonding abilities and hydrophobicity. The propensity for cyt c 1 to bind small molecules that displace the native methionine ligand may render it capable of performing non-standard reactions, such as peroxidation, and the generation of signaling molecules, as is now well recognized for cyt c (65) (66) (67) (68) .
The kinetics and mechanistic implications of imidazole binding to cyt c 1 are described in the following article (Kokhan et al., accompanying article). °C . Inset: Absorption changes around λ=700 nm. Conditions: 1.5 µM bc 1 in 50 mM Tris, pH 8, 100 mM NaCl, 20 mM cholate, 100 µM ferricyanide, was mixed with 1 mM imidazole (final concentration) and spectra were taken at 15, 30, 60, and 300 sec after mixing. Interaction of Im with the ascorbate-reduced bc 1 complex was measured similarly, except the buffer contained 1 mM ascorbate and 10 µM DAD in place of 100 µM ferricyanide. All difference spectra obtained in the presence of ascorbate were virtually identical and only the last one is shown, after 5 min of incubation with imidazole. Figure 2 . The effect of imidazole on the reducibility of cyt c 1 in bc 1 complex. Cyt bc 1 stock (≈20µM) in 50 mM Tris, pH 8.0, 100 mM NaCl, 0.01% DM, plus 100 µM ferricyanide to fully oxidize the complex, were incubated on ice for 5 hours without (A) or with (B) 50 mM imidazole. Samples were then diluted 20-fold and oxidized spectra recorded. 1mM ascorbate/10 uM DAD was then added and spectra taken for up to a minute to ensure that equilibrium was reached. The samples were then reduced with a few crystals of sodium dithionite and fully reduced spectra were obtained after 20-30 sec. Left: the heme-ligating methionine and adjacent residues in cytochrome c 2 of Rba. sphaeroides without (black) and with (magenta) imidazole bound (imidazole not shown). In the imidazole-bound state, the "hinge", located between two long anchoring α-helices (cyan cylinders), has undergone a conformational change coupled to the methionine movement, making room in the heme pocket for small ligand binding. PDB databank entries 1CXA and 1CXC (13) . Right: the structure of the "hinge" region of cytochrome c 1 from Rba. sphaeroides. The heme is ligated by Met185 (shown in black). The two long α-helices (cyan cylinders) closest to Met185 are separated by 68 amino acids. The disulfide bond between Cys145 and Cys169 (shown in blue) is present only in cytochrome c 1 from Rhodobacter and is essential to maintain the physiological high potential. PDB databank entry 2FYN (44) . The figure was prepared with VMD (69). by guest on September 16, 2017 
